Zovirax Iv 250mg Injection

Zovirax Iv 250mg Injection

S4
PDF Leaflet Revision Date: 27 January 2023

API: Aciclovir | Company: Gsk

Clinical Summary

Quick overview from the medicine insert

Indication

Treatment and prophylaxis of herpes simplex and varicella zoster infections in immunocompromised patients.

Dosage (summary)

5 mg/kg every 8 hours for herpes simplex; 10 mg/kg every 8 hours for varicella zoster.

Special Populations

  • Elderly
  • Renal impairment

Pregnancy & Breastfeeding

Safety in pregnancy and lactation not established; avoid breastfeeding during treatment.

Key Drug Interactions

  • Probenecid
  • Cimetidine
  • Ciclosporin
  • Tacrolimus

Contraindications

  • Hypersensitivity to acyclovir or valaciclovir

Common side effects

  • Nausea
  • Vomiting
  • Rashes
  • Phlebitis
  • Increased blood urea

Counselling Points

  • Maintain hydration
  • Administer by slow infusion
  • Monitor for side effects

Serious warnings

  • Risk of neurological side effects in renal impairment
  • Monitor renal function
Important Disclaimer

The Zovirax Iv 250mg Injection professional information leaflet below is the property of Gsk and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>

Healthcare Professionals Only

This content is for registered healthcare professionals

Sign in or create a free account to read the full package insert.

Free for HPCSA-registered professionals. Powered by Medinsert.

Successfully Stashed! 💊

This package insert has been safely stored in your digital medical cabinet. No prescription needed to view it later!

View My Favourites